# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-13-007055
Filing Date
2013-12-09
Accepted
2013-12-09 14:15:44
Documents
25
Period of Report
2013-12-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | f8k120513_actinium.htm | 8-K | 27469
2 | ACTINIUM PHARMACEUTICALS, INC. CORPORATE PRESENTATION. | f8k120513ex99i_actinium.htm | EX-99.1 | 15690
3 | ACTINIUM PHARMACEUTICALS, INC. PRESS RELEASE ISSUED DECEMBER 5, 2013. | f8k120513ex99ii_actinium.htm | EX-99.2 | 14227
4 |  | logo.jpg | GRAPHIC | 7031
5 |  | slide1.jpg | GRAPHIC | 106984
6 |  | slide2.jpg | GRAPHIC | 111023
7 |  | slide3.jpg | GRAPHIC | 32343
8 |  | slide4.jpg | GRAPHIC | 53202
9 |  | slide5.jpg | GRAPHIC | 87563
10 |  | slide6.jpg | GRAPHIC | 59510
11 |  | slide7.jpg | GRAPHIC | 59170
12 |  | slide8.jpg | GRAPHIC | 48396
13 |  | slide9.jpg | GRAPHIC | 51668
14 |  | slide10.jpg | GRAPHIC | 59421
15 |  | slide11.jpg | GRAPHIC | 72681
16 |  | slide12.jpg | GRAPHIC | 57958
17 |  | slide13.jpg | GRAPHIC | 40071
18 |  | slide14.jpg | GRAPHIC | 53878
19 |  | slide15.jpg | GRAPHIC | 39595
20 |  | slide16.jpg | GRAPHIC | 60979
21 |  | slide17.jpg | GRAPHIC | 59529
22 |  | slide18.jpg | GRAPHIC | 85343
23 |  | slide19.jpg | GRAPHIC | 43484
24 |  | slide20.jpg | GRAPHIC | 53263
25 |  | slide21.jpg | GRAPHIC | 29242
| Complete submission text file | 0001213900-13-007055.txt |  | 1814140

Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52446 | Film No.: 131265215
SIC: 6770 Blank Checks